| Urease as a virulence factor in experimental cryptococcosis GM Cox, J Mukherjee, GT Cole, A Casadevall, JR Perfect Infection and immunity 68 (2), 443-448, 2000 | 624 | 2000 |
| Characterization of a Murine Monoclonal Antibody toCryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies A Casadevall, W Cleare, M Feldmesser, A Glatman-Freedman, ... Antimicrobial agents and chemotherapy 42 (6), 1437-1446, 1998 | 346 | 1998 |
| Protective murine monoclonal antibodies to Cryptococcus neoformans J Mukherjee, MD Scharff, A Casadevall Infection and immunity 60 (11), 4534-4541, 1992 | 343 | 1992 |
| Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in Infection A Casadevall, J Mukherjee, SJN Devi, R Schneerson, JB Robbins, ... Journal of Infectious Diseases 165 (6), 1086-1093, 1992 | 236 | 1992 |
| Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Mukherjee, G Nussbaum, MD Scharff, A Casadevall The Journal of experimental medicine 181 (1), 405-409, 1995 | 214 | 1995 |
| Microevolution of a Standard Strain ofCryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes SP Franzot, J Mukherjee, R Cherniak, LC Chen, JS Hamdan, ... Infection and immunity 66 (1), 89-97, 1998 | 201 | 1998 |
| Monoclonal antibody based ELISAs for cryptococcal polysaccharide A Casadevall, J Mukherjee, MD Scharff Journal of immunological methods 154 (1), 27-35, 1992 | 178 | 1992 |
| Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Mukherjee, A Casadevall, MD Scharff The Journal of experimental medicine 177 (4), 1105-1116, 1993 | 160 | 1993 |
| Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B J Mukherjee, LS Zuckier, MD Scharff, A Casadevall Antimicrobial agents and chemotherapy 38 (3), 580-587, 1994 | 159 | 1994 |
| Human Stx2-Specific Monoclonal Antibodies Prevent Systemic Complications of Escherichia coli O157:H7 Infection J Mukherjee, K Chios, D Fishwild, D Hudson, S O'Donnell, SM Rich, ... Infection and immunity 70 (2), 612-619, 2002 | 146 | 2002 |
| Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice S Mukherjee, S Lee, J Mukherjee, MD Scharff, A Casadevall Infection and immunity 62 (3), 1079-1088, 1994 | 141 | 1994 |
| mRNA mediates passive vaccination against infectious agents, toxins, and tumors M Thran, J Mukherjee, M Pönisch, K Fiedler, A Thess, BL Mui, MJ Hope, ... EMBO molecular medicine 9 (10), 1434-1447, 2017 | 139 | 2017 |
| Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. J Mukherjee, LA Pirofski, MD Scharff, A Casadevall Proceedings of the National Academy of Sciences 90 (8), 3636-3640, 1993 | 134 | 1993 |
| Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease J Steele, J Mukherjee, N Parry, S Tzipori The Journal of infectious diseases 207 (2), 323-330, 2013 | 118 | 2013 |
| A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2 JM Tremblay, J Mukherjee, CE Leysath, M Debatis, K Ofori, K Baldwin, ... Infection and immunity 81 (12), 4592-4603, 2013 | 103 | 2013 |
| A novel strategy for development of recombinant antitoxin therapeutics tested in a mouse botulism model J Mukherjee, JM Tremblay, CE Leysath, K Ofori, K Baldwin, X Feng, ... PloS one 7 (1), e29941, 2012 | 100 | 2012 |
| Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide J Rivera, J Mukherjee, LM Weiss, A Casadevall The Journal of Immunology 168 (7), 3419-3427, 2002 | 94 | 2002 |
| Human Antibody against Shiga Toxin 2 Administered to Piglets after the Onset of Diarrhea Due to Escherichia coli O157:H7 Prevents Fatal Systemic Complications AS Sheoran, S Chapman-Bonofiglio, BR Harvey, J Mukherjee, ... Infection and immunity 73 (8), 4607-4613, 2005 | 86 | 2005 |
| Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans SL Zebedee, RK Koduri, J Mukherjee, S Mukherjee, S Lee, DF Sauer, ... Antimicrobial agents and chemotherapy 38 (7), 1507-1514, 1994 | 81 | 1994 |
| Production and characterization of protective human antibodies against Shiga toxin 1 J Mukherjee, K Chios, D Fishwild, D Hudson, S O'Donnell, SM Rich, ... Infection and immunity 70 (10), 5896-5899, 2002 | 80 | 2002 |
